Form D · Biotechnology
VISTA THERAPEUTICS INC
Santa Fe, NM · CIK 0001458925
Offering snapshot reported Jan 14, 2010 · SEC filing
- Reported sold
- $162K Offering amount: $1.5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $4.5K Reported outside-investor minimum
- First sale
- Dec 31, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 14, 2010 | Initial | $162,364 | No comparison | 6 | SEC filing |
| Mar 9, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 05, 06, 46
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-128210
Source: Form D, filed Jan 14, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles Call | Director |
| John W. Elling | Director |
| Spencer W. Farr | Director, Executive |
| Charles M. Lieber | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3900 Paseo Del Sol
Santa Fe, NM, 87507
Santa Fe, NM, 87507